Concepedia

Ewald Kolesnik

EK

Statistics

Publications

31

Citations

1.4K

H-Index

18

Active since

2015

Affiliations

Medical University of Graz(Current)

Medical University of Vienna

Center For Biomarker Research In Medicine

BioTechMed-Graz

Khalifa University of Science and Technology

Ewald Kolesnik is an author at Medical University of Graz specializing in medicine, cardiology, and pharmacology.

ORCID

Publications per year

2015–2024

31

Publications

31

Alternate Day Fasting Improves Physiological and Molecular Markers of Aging in Healthy, Non-obese Humans

Slaven Stekovic, Sebastian J. Hofer, Norbert J. Tripolt et al. · Cell Metabolism · 2019 · 402 citations · Full text

, , +12

Empagliflozin in acute myocardial infarction: the EMMY trial

Dirk von Lewinski, Ewald Kolesnik, Norbert J. Tripolt et al. · European Heart Journal · 2022 · 290 citations · Full text

, , +14

Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial

Axel Bauer, Michael Schreinlechner, Nikolay Sappler et al. · The Lancet Respiratory Medicine · 2021 · 105 citations · Full text

, , +13

Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction—The EMMY trial

Norbert J. Tripolt, Ewald Kolesnik, Peter N. Pferschy et al. · American Heart Journal · 2019 · 72 citations

, , +15

Exenatide exerts a PKA-dependent positive inotropic effect in human atrial myocardium

Markus Wallner, Ewald Kolesnik, Klemens Ablasser et al. · Journal of Molecular and Cellular Cardiology · 2015 · 63 citations

, , +13

1–5 of 31